Cyprus vs IBRD only: Cause of death, by non-communicable diseases, female
Cyprus
83.6%
in 2021
IBRD only
68.6%
in 2021
Cyprus rank
20th
IBRD only rank
18th
Cause of death, by non-communicable diseases, female over time
- Cyprus
- IBRD only
How they compare
Cyprus currently reports 83.6% against 68.6% in IBRD only, a difference of 15.0%.
That makes Cyprus's figure about 1.2 times IBRD only's.
Across all 6 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 20th and IBRD only ranks 18th of 185 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | IBRD only | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.8% | 66.5% | 24.4% | Cyprus |
| 2010s | 90.9% | 78.5% | 12.4% | Cyprus |
| 2020s | 86.5% | 72.0% | 14.5% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Cyprus or IBRD only?
- Cyprus, at 83.6% against 68.6% in IBRD only as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Cyprus and IBRD only?
- 15.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and IBRD only?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and IBRD only rank globally for cause of death, by non-communicable diseases, female?
- Cyprus ranks 20th and IBRD only ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.